SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: RT who wrote (9020)6/3/1998 2:42:00 PM
From: Colby  Read Replies (1) | Respond to of 23519
 
<<The next thing I expect to see on the wire services:
Vivus Refuses To Answer Phone.>>

It will probably read

"The only thing VVUS management finds hard is answering the phone. In a study done by independent sources, conducted over a 1 year period, VVUS management was found effective in 0% of all responses to negative PR. The stock has fallen from a high of 40 to a recent bottom of 7 and management has only been able to speed up the free fall.
The company was unavailable for comment. Sources close to the company say they are this close to developing some gene therapy pill to treat retardation in management.
This study was paid for by VVUS sponsored shorts for a cheaper stock price."

From Hemreuter's,
I'm Colby wishing you a harder tomorrow.



To: RT who wrote (9020)6/3/1998 3:58:00 PM
From: Tunica Albuginea  Read Replies (1) | Respond to of 23519
 
RT, I know it is frustrating when Vivus doesn't answer the phone.Maybe at least an explanatory recorded message might have been in order.But there are a lot of things happening now so that would have been a very long message. I believe Vivus management is just executing their plan.The FDA approval will come.This was a great buying opportunity today,

TA

( it may make you feel better perhaps if an FDA recall for Viagra comes because of retinal damagefrom Viagra and PFE drops 40%? to $60? I will bookmark this post,gg, for future reminders.
TA